CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)C4=NN(c5ccccc5)C(=O)C4)cc(OC)c3)cc2C(F)(F)F)CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?